Answers are grounded in this paper and cite their sources.
RNA therapies have demonstrated promising potential for a myriad of clinical treatments in treating various diseases. However, significant unresolved obstacles are achieving precise delivery to specific tissues. This Viewpoint examines the inherent obstacles encountered by ligand-functionalized oligonucleotide conjugates and RNA-LNPs and the strategies to overcome them to achieve the desired therapeutic outcomes.
No takes yet. Share an insight, caveat, or question.
Ang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: